Maternal serum alpha-fetoprotein (AFP) levels are higher in Black than White pregnant women, supporting the use of accounting for these differences in prenatal open neural tube defect (ONTD) screening ...
Identification of a molecular profile that may predict early relapse in patients undergoing multimodality therapy in muscle-invasive bladder cancer (MIBC). Diverse long-time progression-free survival ...
Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer We screened 1,018 HBV carriers by serum alpha-fetoprotein (AFP) measurement and abdominal ultrasonography ...
The US Food and Drug Administration (FDA) has approved ramucirumab (Cyramza, Lilly) as monotherapy for the treatment of patients with hepatocellular carcinoma (HCC) who have an alpha-fetoprotein (AFP) ...
Doctors often monitor tumor markers in the blood to help diagnose and treat liver cancer. Alpha-fetoprotein (AFP) is the most common tumor marker that doctors monitor. Tumor markers, also called ...
A race-based adjustment to test-result values from a common prenatal screening should be discontinued, according to a study published this week in Obstetrics and Gynecology. The adjustment has ...
Serum alpha-fetoprotein (AFP) is the current standard of care and only approved biomarker for hepatocellular carcinoma (HCC), used for diagnosis, outcome prediction, long-term follow-up, and treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results